Robert Debre University Hospital

At Robert Debre University Hospital, clinical trials in oncology and hematology focus on childhood and adolescent cancers and blood disorders, including acute lymphoblastic leukemia, acute myeloid leukemia, lymphoma, neuroblastoma-related solid tumors, immune thrombocytopenia, and sickle cell disease. These studies are mainly designed to test new treatment options, improve response rates, and better understand long-term outcomes in young patients.

• Acute lymphoblastic leukemia and acute myeloid leukemia studies aimed at improving remission and survival
• Lymphoma and solid tumor research evaluating new anti-cancer therapies
• Blood disorder trials focused on treatment effectiveness and safety in children

This activity reflects a strong pediatric cancer research program with an emphasis on safer, more effective care for complex hematologic and oncologic diseases.

The site’s pediatric nephrology research includes trials in kidney transplantation, idiopathic nephrotic syndrome, primary hyperoxaluria, hemolytic uremic syndrome, and transplant-related complications. The main goals are to improve graft survival, reduce immune rejection, and evaluate therapies that protect kidney function in children and adolescents.

• Kidney transplant studies assessing better immunosuppression and desensitization approaches
• Nephrotic syndrome and hyperoxaluria trials focused on disease control and kidney preservation
• Hemolytic uremic syndrome research evaluating supportive and targeted treatment strategies

These studies highlight a broad effort to advance renal care for pediatric patients with chronic and high-risk kidney conditions.

Clinical research in respiratory diseases at this hospital centers on asthma, including severe and uncontrolled forms in children and adolescents, as well as cystic fibrosis and bronchopulmonary dysplasia in newborns. The trials are designed to test new therapies, reduce flare-ups, and improve breathing outcomes across different age groups.

• Severe asthma studies looking at better control of attacks and symptoms
• Cystic fibrosis research assessing long-term treatment benefit
• Neonatal lung disease trials aimed at lowering the risk of chronic breathing problems

This area shows a clear focus on improving pediatric respiratory health through innovative treatment approaches and supportive care.

The hospital also conducts studies in neurology and related fields, including epilepsy, narcolepsy, and developmental neurological conditions such as tuberous sclerosis complex and autism spectrum disorder. The purpose of these trials is to improve seizure control, reduce daytime sleepiness, and explore better symptom management for children and adolescents.

• Epilepsy trials examining new ways to reduce seizure frequency and severity
• Narcolepsy research focused on improving alertness and daily functioning
• Neurodevelopmental disorder studies addressing behavior and associated symptoms

This research strengthens care for young patients living with chronic neurological and developmental conditions.

Trials in immunology at this site address conditions such as Behçet’s disease, familial Mediterranean fever, chronic graft-versus-host disease, and steroid-refractory acute graft-versus-host disease. They aim to improve symptom control, reduce inflammation, and evaluate treatments that may work better for children with difficult-to-manage immune-mediated diseases.

• Autoinflammatory disease research targeting pain and mucosal symptoms
• Transplant complication studies focused on better control of graft-versus-host disease
• Immune disorder trials assessing effectiveness and tolerability of new therapies

The research portfolio shows strong interest in both immune regulation and post-transplant care in pediatric populations.

The site is active in endocrinology and metabolic disease research, with trials in type 1 diabetes, Cushing’s disease, congenital adrenal hyperplasia, generalized lipodystrophy, obesity, and growth disorders such as Turner syndrome and Noonan syndrome. These studies are intended to evaluate treatment effectiveness, improve hormone-related outcomes, and support healthier growth and metabolism in young patients.

• Hormonal disorder trials assessing symptom control and metabolic balance
• Obesity and growth disorder research aimed at improving physical development
• Rare metabolic disease studies focused on long-term disease management

This work reflects a broad commitment to advancing care for complex pediatric endocrine and metabolic conditions.

Clinical trials in maternal-fetal medicine and neonatology include studies on pregnancy hypertension, pre-eclampsia, premature rupture of membranes, fetal growth restriction, and prematurity in newborns. The research is aimed at preventing complications, improving pregnancy outcomes, and supporting the health of both mother and baby.

• Pregnancy complication studies focused on reducing maternal and fetal risk
• Preterm birth research evaluating ways to improve newborn outcomes
• Neonatal lung disease trials seeking better support for high-risk infants

These studies show that Robert Debre University Hospital contributes to care across the full spectrum of pregnancy and early-life health.

Another important research area covers infectious diseases and prevention, including bacterial infections, viral infections, and pneumococcal disease. Trials in this space are designed to assess new treatments for serious infections and to improve protection through vaccination in children with increased medical risk.

• Bacterial and viral infection studies evaluating treatment response
• Vaccine research aimed at strengthening prevention in vulnerable patients
• Post-transplant infection trials focused on difficult-to-treat infectious complications

This portfolio supports better infection control and prevention strategies for pediatric patients with complex health needs.

The site also includes studies in psychiatry, psychology, and digestive health, particularly in children with autism spectrum disorder and gastrointestinal symptoms. These trials explore whether symptom-targeted treatments can improve behavior, sleep, digestive comfort, and overall quality of life.

• Autism spectrum disorder research evaluating behavioral and gastrointestinal outcomes
• Digestive symptom studies focused on improving everyday comfort
• Developmental condition trials looking at broader symptom relief and functioning

This area adds a valuable multidisciplinary dimension to the hospital’s pediatric research activity.